Welcome to our dedicated page for SCOTTS MIRACLE-GRO CO SEC filings (Ticker: SMG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on SCOTTS MIRACLE-GRO CO's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into SCOTTS MIRACLE-GRO CO's regulatory disclosures and financial reporting.
Scotts Miracle-Gro director Mark D. Kingdon reported acquiring additional company stock. On January 30, 2026, he acquired 3,271 common shares of The Scotts Miracle-Gro Company at a stated price of $0 per share.
Following this transaction, Kingdon directly beneficially owned 11,493 common shares of Scotts Miracle-Gro. The filing lists him as a director and shows no derivative securities transactions for this date.
Scotts Miracle-Gro executive Dimiter Todorov, EVP, Chief Legal Officer and Corporate Secretary, received a grant of stock options on January 30, 2026. The award covers 18,976 stock options with an exercise price of $64.22 per common share and expires on January 30, 2036.
The Scotts Miracle-Gro Company reported results of its January 26, 2026 Annual Meeting, where shareholders approved an amendment and restatement of the Long-Term Incentive Plan to increase the maximum number of common shares available for grant by 2,750,000 Common Shares.
Shareholders elected four directors to terms ending at the 2029 annual meeting, approved on an advisory basis the compensation of named executive officers, and ratified Deloitte & Touche LLP as independent auditor for the fiscal year ending September 30, 2026. About 91% of the 58,007,149 Common Shares outstanding as of December 1, 2025 were represented, establishing a quorum. Beginning January 30, 2026, the company will use updated equity award agreement forms for employees and non-employee directors under the Long-Term Incentive Plan.
Scotts Miracle-Gro executive Mark J. Scheiwer, EVP, CFO & CAO, reported an award of phantom stock on 01/26/2026. He received 10.367 phantom stock units at a reference price of $62.70 per unit, increasing his phantom stock holdings to 1,207.573 units, held directly.
Each phantom stock unit represents the right to receive one common share of Scotts Miracle-Gro or its cash value. These phantom stock units are payable in cash after his employment with the company ends, and he may transfer the units into an alternative investment at any time.
Scotts Miracle-Gro Chairman and CEO James Hagedorn received 1,329.114 phantom stock units on January 26, 2026. These units were valued at $62.7 per phantom share and are linked to Scotts Miracle-Gro common shares.
After this award, Hagedorn beneficially owns 233,802.271 phantom stock units directly. Each phantom unit represents the right to receive one common share of the company or its cash value, generally payable in cash after his employment with the company ends.
The Scotts Miracle-Gro Company filed a current report to note that it has released a news announcement covering its financial results for the three months ended December 27, 2025 and its financial condition as of that date. The company furnished this news release as Exhibit 99.1, making the detailed figures and commentary available through the attached exhibit rather than in the body of the report.
The Scotts Miracle-Gro Company executive Mark J. Scheiwer reported a small share acquisition through a company retirement plan. On 12/31/2025, he acquired 3.104 common shares of Scotts Miracle-Gro at $48.32 per share, coded as transaction type J. After this transaction, he beneficially owned 15,285.853 common shares directly and 493.482 common shares indirectly through a 401(k) plan. Scheiwer is listed as the company’s EVP, CFO & CAO, and this Form 4 is filed for a single reporting person.
Scotts Miracle-Gro Company Chairman and CEO James Hagedorn, a director and more than 10% owner, reported several equity transactions in company common shares. On January 2, 2026, 941.612 phantom stock units were settled for the same number of common shares, and 42.377 shares were disposed of, typically reflecting shares withheld to cover obligations. A prior credit of 41.391 common shares on December 31, 2025, is also reported.
Following these transactions, Hagedorn beneficially owned 104,074.4598 common shares directly, 31,533.64 shares through a 401(k) plan, and 997,910 shares indirectly through Hagedorn Partnership, L.P. He also continued to hold 232,473.157 phantom stock units, each economically equivalent to one common share, which are payable in cash following termination of employment or may be moved into alternative investments.
Scotts Miracle-Gro Company executive reports a small share acquisition. Executive Vice President & Chief of Staff Christopher J. Hagedorn filed a Form 4 showing that on 12/31/2025 he acquired 4.491 common shares of Scotts Miracle-Gro at a price of $48.32 per share, in a transaction reported under code J. Following this transaction, he beneficially owned 60,111.2874 common shares, held in direct ownership.
The Scotts Miracle-Gro Company executive Mark J. Scheiwer reported acquiring 9.846 phantom stock units on 12/26/2025 at a reference price of $57.76 per unit. Each phantom stock unit represents the right to receive one common share of Scotts Miracle-Gro or the cash value of a share. These phantom stock units are payable in cash following the end of his employment with the company, and he may transfer them into an alternative investment at any time. After this transaction, Scheiwer beneficially owned 1,197.206 phantom stock units held directly.